The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial (Q36521262)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 July 2012
edit
Language Label Description Also known as
English
The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial
scientific article published on 24 July 2012

    Statements

    The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial (English)
    Robert Frederich
    Robert McNeill
    Niklas Berglind
    Douglas Fleming
    Roland Chen
    24 July 2012

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit